Navigation Links
BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
Date:8/13/2008


Toronto Stock Exchange Symbol: MS

- Milestone triggers $10 million payment from Eli Lilly and Company -

EDMONTON, Aug. 13 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Drug Safety Monitoring Board (DSMB) for the MAESTRO-01 trial has conducted the scheduled interim analysis of efficacy and safety and has recommended that the trial continue to completion. MAESTRO-01 is the pivotal phase II/III Canadian and European study of dirucotide (MBP8298) in patients with secondary progressive MS.

The interim analysis included patients from the first 200 to complete MAESTRO-01 and assessed the likelihood of the study reaching its primary endpoint at the end of the trial in MS patients with the target HLA-DR2 and/or HLA-DR4 immune response genes. The DSMB analysis also included a scheduled review of safety information.

Based on the DSMB decision, Eli Lilly and Company has agreed to provide the $10 million milestone payment to BioMS as part of the terms of the licensing and collaboration agreement.

"We are very encouraged by the safety board's recommendation," said Kevin Giese, President and CEO of BioMS Medical. "This positive review is an important milestone for BioMS and our partner, Eli Lilly and Company, and moves us one step closer to our goal of bringing this important therapy to multiple sclerosis patients."

"We are pleased by the results of the interim analysis and look forward to final efficacy and safety data from this trial next year," said Dr. Mark Freedman, Professor of Neurology at the University of Ottawa and Director of the MS Research Clinic at the Ottawa Hospital. "If successful, this novel therapy administered only twice per year, could help a large underserved population with late stage MS."

About MAESTRO-01

----------------

Dirucotide (MBP8298) is being studied in fo
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioMS Medical Announces Second Quarter 2008 Results
2. BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
3. BioMS Medical to present at BMO Healthcare Conference
4. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
5. BioMS Medical to present at Jefferies Healthcare Conference
6. BioMS Medical to present at 2008 BIO International Convention
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medical announces first quarter 2008 results
9. BioMs Medical to present at TIDES(R) Conference
10. BioMS Medical to present at Rodman and Renshaw Global Healthcare Conference
11. BioMS Medical Provides Update On Pipeline Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, SANDIEGO,Nov.25/PRNewswire-FirstCall/--Ardea...arryD.Quart,Pharm.D.,presidentandchiefexecutiveoff...areConference. , ,Presentationdetailsareasfollows...:Tuesday,December1,2009,Time:2:00p.m.EasternTime,L...ahref=,http://www.corporate-ir.net/ireye/,target=...
(Date:11/24/2009)...,, HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Na...ndcommunicationssystemsandservicesforthecommercial...titscommercialbusinessgrouphasbeenawardedacontract...fortheLevel4bio-safetylab(BSL-4)replacementfacilit...Diseases(USAMRIID)atFortDetrickinFrederick,Md. ,...
(Date:11/24/2009)... The New York investment ba... (ASX:NEU) has agreed an AU$6.7 mil convertible no...estor. The private placement was arranged by KTA C...dvisor. , New York (PRWEB...vestment bank KTA Capital, LLC ("KTA Capital&...
(Date:11/24/2009)...,, CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswire...isacquiringtheassetsofHylandSeeds,adivisionofThomp...eedswillfurtherexpandDowAgroSciences,currentseedsb...artStax(TM) in 2010 andDowAgroSciencesHerbicideT...lcloseisexpectedinthenearfuture. ,, "Thisacquis...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
... DIEGO, Feb. 3 Gen-Probe Incorporated (Nasdaq: ...oined the Company as senior vice president, resear...dd Eric,s scientific expertise and leadership to o...rl Hull, Gen-Probe,s president and chief operating...role in helping our R&D team drive short-, med...
... , Many health plans are moving to in-sour...s to control costs and improve member outcomes , ...ed Health Management Solution(IHMS) platform fully...T platform , , , , , , , Blue Cr...nstallation to improve care and manage members, he...
...ENCIA, Calif., Feb. 2 MannKind Corporation (Nasda...d commercializing treatments for diabetes and canc...th Annual Biotechnology Industry Organization BIO ...9, 2009 at 2:15 PM (EST) at the Hilton Waldorf Ast...ntation, the Company will host a breakfast meeting...
Other Biology Technology:Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development 2Alere Offers Single-Source Solution for Health Plans Seeking to In-Source Health Management Programs 2Alere Offers Single-Source Solution for Health Plans Seeking to In-Source Health Management Programs 3Alere Offers Single-Source Solution for Health Plans Seeking to In-Source Health Management Programs 4MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference 2
(Date:11/25/2009)...ne produced in the stomach, may be used to boost r...n,s disease, Yale School of Medicine researchers r...e Journal of Neuroscience . , Parkinson,s disea... in an area of the midbrain known as the substanti...ion. Reduced production of dopamine in late-stage...
(Date:11/25/2009)...of a lifetime, the heart pumps some 250 million li... this, the muscle fibers of the heart have to be e... Wolfgang Rottbauer, vice chair of the Department ...(Chairman: Prof. Dr. H. A. Katus), has discovered ... the smallest muscular unit, the sarcomere. In coo...
(Date:11/24/2009)...s opening new doors to understanding how sounds as...of a marine mammal or if they hear it at all. , ...nners that NASA uses to detect flaws in the space ...ing scientists to peek inside the giant head of a ...nsional replicas of a whale,s hearing anatomy usin...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 1GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 2Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 1Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 1Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 3Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 4
...ids in fish oils have been well documented helpin... quality and reducing methane emissions. , These ...ing emissions is important for the environment, as...ribution to greenhouse gas levels. Today (Monday 3...n reported that by including 2% fish oil in the di...
...hers have identified a gene that suppresses tumor ...cer. The finding is reported today in the journal ...analysis of a group of enzymes implicated in skin ... analysis found that one-quarter of human melanoma...ode for matrix metalloproteinase (MMP) enzymes. Th...
...ne - one that is common to many cancers and affect...example - a gene on the X chromosome called UTX - ...% of esophageal cancers. , UTX plays a role in ov... it is possible that other genes with similar role...umor types. This is the first example of mutations...
Other Biology News:Skin cancer study uncovers new tumor suppressor gene 2Skin cancer study uncovers new tumor suppressor gene 3Getting down to cancer basics 2Getting down to cancer basics 3
... 10-2 is a microprocessor controlled, high speed f...eptionally smooth operation make the Lambda 10-2 i...nce microscopy, ratio imaging, spectrophotometry, ...pid and accurate aperture positioning. The Lambda ...
Fluoroskan Ascent FL, 100-240 V, one dispenser from Thermo Scientific
...is an enzyme that catalyzes the hydrolysis of,star...ins. The,level of a-amylase in various fluids of t...iagnosis of disease states including,pancreatitis ...mportant enzymes for industrial applications rangi...
Custom siRNA Synthesis from Thermo Scientific
Biology Products: